Variant report
Variant | nsv900495 |
---|---|
Chromosome Location | chr13:70612412-70658404 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-BORA-23 | chr13:70615319-70615369 | NONHSAT034249 |
2 | lnc-BORA-23 | chr13:70639819-70640550 | NONHSAT034249 |
3 | lnc-BORA-23 | chr13:70639503-70639559 | NONHSAT034249 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142774363 | chr13:70616400-70616401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs368688223 | chr13:70616417-70616418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs148965564 | chr13:70616427-70616428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs554512541 | chr13:70616476-70616477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545135387 | chr13:70616669-70616670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs574575538 | chr13:70616671-70616672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540095125 | chr13:70616716-70616717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs369097139 | chr13:70616717-70616718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs553663474 | chr13:70616748-70616749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576410491 | chr13:70616790-70616791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs545429839 | chr13:70616796-70616797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs562596777 | chr13:70616846-70616847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs531355135 | chr13:70616855-70616856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs541912834 | chr13:70616904-70616905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs561284083 | chr13:70616935-70616936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs111749350 | chr13:70616939-70616940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs76875650 | chr13:70616962-70616963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs183777352 | chr13:70616976-70616977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs142862185 | chr13:70617013-70617014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs79303832 | chr13:70617038-70617039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs201964935 | chr13:70617064-70617065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200306786 | chr13:70617068-70617069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs151097000 | chr13:70617097-70617098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557996542 | chr13:70617161-70617162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs113460319 | chr13:70617194-70617195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs537903857 | chr13:70617203-70617204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs555052179 | chr13:70617223-70617224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs142553856 | chr13:70617257-70617258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188784970 | chr13:70617264-70617265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs146684288 | chr13:70617279-70617280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs371122104 | chr13:70617284-70617285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs190591596 | chr13:70617307-70617308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs549729914 | chr13:70617336-70617337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs139352929 | chr13:70617346-70617347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs139407571 | chr13:70617371-70617372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs539046198 | chr13:70617378-70617379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs535392638 | chr13:70617381-70617382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs555839439 | chr13:70617393-70617394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs187183064 | chr13:70617618-70617619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs560758039 | chr13:70617632-70617633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs532903222 | chr13:70617633-70617634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs191639952 | chr13:70617637-70617638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs184536643 | chr13:70617649-70617650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs547368339 | chr13:70617733-70617734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs565673509 | chr13:70617741-70617742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs531745381 | chr13:70617749-70617750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs539477499 | chr13:70617750-70617751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs548363160 | chr13:70617764-70617765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs187508028 | chr13:70617771-70617772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs377448940 | chr13:70617812-70617813 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Prostate cancer | 22341455 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:70616400-70617200 | Enhancers | Fetal Intestine Small | intestine |
2 | chr13:70617000-70617400 | Enhancers | Fetal Intestine Large | intestine |
3 | chr13:70617600-70618200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr13:70618200-70620800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr13:70620800-70621600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr13:70622800-70623200 | Enhancers | H1 Cell Line | embryonic stem cell |
7 | chr13:70623000-70623600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr13:70624800-70625400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
9 | chr13:70639200-70639600 | Enhancers | Fetal Brain Female | brain |
10 | chr13:70652600-70655600 | Enhancers | Fetal Heart | heart |
11 | chr13:70653800-70654400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
12 | chr13:70653800-70654400 | Enhancers | Fetal Brain Female | brain |
13 | chr13:70654000-70654600 | Enhancers | Fetal Brain Male | brain |
14 | chr13:70654600-70656400 | Weak transcription | Fetal Brain Male | brain |
15 | chr13:70655600-70661000 | Weak transcription | Fetal Heart | heart |
16 | chr13:70656400-70656600 | Enhancers | Fetal Brain Male | brain |
17 | chr13:70658200-70658600 | Active TSS | HepG2 | liver |
18 | chr13:70658400-70659000 | Active TSS | Hela-S3 | cervix |